Seeking Alpha
07 Oct 2026, 11:30 UTC · 1h ago
West Pharma: Still A Buy, But Expectations Are Rising
Impact · against what's priced in
The article provides no new catalysts for West Pharma, as it reiterates growth drivers already accounted for in the stock's valuation. Because the market is already paying for the GLP-1 trajectory and Annex 1 potential, the confirmation of these trends does not move the needle.
- WST+0.00
Already priced in
- The price assumes
high-teens growth in GLP-1 components
The report of double-digit growth from GLP-1s is already assumed by the market, which pays for high-teens growth in those components.
What WST's price assumes · Sep 10
Search tags
